More than ever over the last 12 months, our use of patient data has been essential to support public health and gain information about vital medicines. In this article, we interview Dr Sheuli Porkess, Director of Actaros Consultancy for her insights on the latest trends, regulatory adoption and her expectations and hopes for the future.
Following the success of our first virtual breakfast briefing in February 2021, PharmaMedic invites consultants and those thinking of becoming a consultant, to register for our new event on Thursday, April 22nd 2021. Our expert presenters will discuss key issues facing pharmaceutical consultants in 2021- navigating #IR35, establishing your vision and adapting to change. Click here to learn more and register.
We've championed the benefits of outsourced medical affairs solutions for over a decade. During the last 12 months, the skills and experience of our consultants have been needed more than ever to help pharmaceutical clients navigate through the COVID-19 crisis. Read more to learn how.
We enjoyed welcoming delegates to our first virtual breakfast briefing earlier this month discussing the trends shaping medical and regulatory affairs in 2021. In this round-up, we share some of the key discussion points- from a post-Brexit MHRA, to the new ILAP scheme. We look forward to exploring these issues further in future PharmaMedic events soon.
As 2021 gets underway, in the context of continued pandemic response and post-Brexit environment, the role of regulatory affairs in pharma is likely to be more instrumental than ever. In this article, we share a preview of the key regulatory trends that Dr Zubair Hussain will discuss at our upcoming breakfast briefing on the 10th February. Read on to learn more about the ways regulatory affairs is set to underpin innovation and sign up to attend our virtual briefing.
We marked our 5-year anniversary as a client of the London Bioscience Innovation Centre (LBIC) recently and featured in its Winter newsletter alongside Prokarium, MicrosensDx and VirTus and others.
2020 was certainly one of the most unusual years we can recall. Thank you to our clients, consultants and readers for following our news stories. We wrote on a range of topics and we recap the most widely read articles of last year in this short read.
PharmaMedic is delighted to announce the launch of a new series of virtual events starting with a breakfast briefing on Wednesday 10th February 2021 at 08:00 am. In this first event, we will cover the 2021 Medical and Regulatory Affairs Outlook. For full details and how to register please read further.
PharmaMedic was delighted to support and sponsor the Excellence in Rare Diseases and Orphan Drugs category at the recent PMEA awards. Read our article to find out more.
In our latest article, we explore how PMC supports Dr Kathrine Scott of Gedeon Richter with new product launches and day to day copy approval. Read on to learn how we are helping this small medical team make a real impact.
